Company intelligence
Speyside
Leader in Corporate Affairs & Public Policy across the Global South
About Speyside
Speyside Group | Government Affairs & Public Policy Advisory | Reputation | LATAM, Asia, EMEA | Emerging Markets | Regulatory & Political Risk Speyside is a leading corporate affairs, government relations, and public policy consultancy across emerging markets including Latin America, Asia Pacific, and EMEA. We support both the private and public sectors in navigating complex regulatory, political, and reputational environments. Our specialist global practice groups work seamlessly with our local on-the-ground teams to deliver insight-driven, pragmatic solutions in every market we operate. Core focus areas: Strategic communications & reputation management – issues management, crisis response, and corporate positioning Stakeholder engagement & government relations – including regulatory affairs, public policy, and multilevel government engagement Market access & investment support – political risk assessment, regulatory strategy, and enabling market entry in emerging economies Regions of expertise: Latin America (Colombia, Brazil, Mexico, Peru, Chile, Argentina) Asia Pacific (India, Indonesia, Vietnam, Philippines, Thailand) EMEA (Middle East, North Africa, Sub-Saharan Africa, Eastern Europe)
Verified activity
Signals from Speyside
3 published signals
Operations & Supply
Speyside notes that three Bundibugyo-specific candidates entered first-in-human trials in July, August, and September.
Reported by Simonetta Santana
Legal & Regulatory
Speyside notes that WHO shifted the trial design from rings to individually randomised contacts on 3 September.
Reported by Simonetta Santana
Legal & Regulatory
Speyside notes that WHO published emergency guidance for Ervebo in Bundibugyo outbreaks within research protocols with a ring randomised controlled trial as the fastest route to real efficacy data.
Reported by Simonetta Santana